Sign in / Join Now
ETFs & Funds
down on high volume. Is there something I'm missing here?
Secondary offering priced at $5. Took it down from $7, horrible penalty to shareholders.
Add a reply...
Latest StockTalks »
people get MACK breaking news and analysis by email alert.
Get email alerts on MACK »
Get latest price
From other sites
Vetr Upgrades Merrimack Following Earnings, Licensing Rumors
at Benzinga (Nov 29, 2016)
First Week of January 2017 Options Trading For Merrimack Pharmaceuticals (MACK)
at TheStreet (Nov 22, 2016)
Merrimack Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for MACK
at TheStreet (Nov 10, 2016)
Merrimack Announces Acceptance For Review Of ANDA Filed By Actavis For Generic Doxorubicin Hydrochloride Liposome Injection (aka DOXIL®)
at TheStreet (Oct 31, 2016)
Interesting MACK Put And Call Options For June 2017
at TheStreet (Oct 25, 2016)